PANEL: Embedding robust commissioning frameworks and processes

** In partnership with Boehringer Ingelheim **

• What actually *is* commissioning?
• Guidelines and frameworks – where do they exist and are they fit for purpose?
• Integrating effective commissioning in new treatment pathways and innovations
• Developing service specifications for commissioning, and aligning with best practice clinical guidance
• Is cancer commissioning an ICB or CA responsibility? How can this best be managed and/or aligned?
• Is commissioning really delivering value? Where is the data and evidence?
• Monitoring commissioning in terms of equity, access, outcomes, experience, operational deliverability, financial impacts
• How do we embed innovation in our commissioning?
• Ensuring you have the right skills within your team